This is a prospective, multicenter, parallel groups, non-interventional, examiner masked, comparative clinical study. Patients that participated in previous Hoya studies, and patients previous implanted with Hoya non-toric monofocal IOLs (sub-study only) will be enrolled in the study. The sample size for this study is based on demonstrating the non-inferiority of the mean distance-corrected intermediate visual acuity (DCIVA) in Group 1 (Site 1) compared with Group 2 (Site 2).
Previously implanted with intraocular lens through 2 previous IOL studies;
Clear intraocular media with no clinically significant opacity, in the investigator's judgment, that would affect visual acuity;
Able to provide informed consent and complete all required study procedures.
Corrected distance visual acuity (CDVA) worse than 0.2 logMAR (or 20/32 Snellen)
Subjects with ongoing medical conditions or treatment that might impact outcomes during the study visit as determined by the investigator.